Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-05

Clinical Trial Update: Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium

View source ↗

Summary

A clinical trial update on the study assessing treatment patterns and outcomes with upadacitinib in adults with inflammatory bowel disease in Belgium; recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis, Crohn's Disease | Status: RECRUITING